This training will provide you with a sense of security in medical practice, which will help you grow personally and professionally”

Cancer patients, on many occasions, present pathologies associated with the oncological process or not, but which require attention and care. One example is cardiovascular pathologies, such as arterial hypertension or venous thromboembolic disease.

The specialist plays a fundamental role in the approach to the oncological process, and his or her diagnostic and therapeutic orientation must be in harmony with those of the rest of the pathologies suffered by the patient.

Cardiovascular involvement is commonly present in the side effects of most treatments for the oncology patient. The management of the medication, as well as of other therapeutic options, is fundamental in the adjustment of the appropriate dosage for medical praxis. Keeping up to date with advances in arterial hypertension and venous thromboembolic disease in oncology patients is a fundamental skill that physicians must possess in their daily clinical practice.

This program is designed to facilitate the specialist's updating process, so that he/she can include in the clinical practice of their patients all the innovations and the latest knowledge about oncological therapeutics.

Update your knowledge with the Postgraduate diploma in Systemic Cardiovascular Disease and Complex Clinical Situations in the Oncologic Patient"

The Postgraduate diploma in Systemic Cardiovascular Disease and Complex Clinical Situations in the Oncologic Patient contains the most complete and up to date scientific program on the market. The most important features of the program include:

• Development of case studies presented by experts on hypertension and venous thromboembolic diseases in cancer patients. The graphic, schematic, and eminently practical contents with which they are created provide scientific and practical information on the disciplines that are essential for professional practice
• New developments in arterial hypertension in the oncology patient
• It contains practical exercises where the self-evaluation process can be carried out to improve learning
• With special emphasis on innovative methodologies in arterial hypertension and venous thromboembolic disease
• All of this will be complemented by theoretical lessons, questions to the Postgraduate diploma, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

This Postgraduate diploma may be the best investment you can make in the selection of a refresher program for two reasons: in addition to updating your knowledge in Systemic Cardiovascular Disease and Complex Clinical Situations in the Oncologic Patient, you will obtain a Postgraduate diploma from TECH Global University"

Its teaching staff includes professionals from the field of hypertension and venous thromboembolic disease in cancer patients, who bring to this training the experience of their work, as well as renowned specialists from prestigious reference societies and universities.

The multimedia content developed with the latest educational technology will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive training program to train in real situations.

The design of this program is based on Problem-Based Learning, by means of which the student must try to solve the different professional practice situations that arise throughout the course. To this end, the student will be assisted by an innovative interactive video system developed by recognized experts in the field of cardiovascular pathology in oncology, with extensive teaching experience.

Increase your decision-making confidence by updating your knowledge through this specialist course"

Make the most of this opportunity to learn about the latest advances in the approach to cardiovascular pathologies in oncology, and improve the care of your patients"

The structure of the contents has been designed by a team of professionals from the best hospitals and universities in the country, aware of the relevance of current training to be able to intervene in the toxic effects of oncological therapies at the cardiac level, and committed to quality teaching through new educational technologies.

The Postgraduate diploma in Systemic Cardiovascular Disease and Complex Clinical Situations in the Oncologic Patient contains the most complete and up to date scientific program on the market"

Module 1. Comprehensive Assessment of the Risk of Cardiotoxicity Development

1.1. Individual Susceptibility to Cardiotoxicity: Genetic Factors
1.2. Individual Susceptibility to Cardiotoxicity: Non-Genetic Factors

1.2.1. Cardiovascular Risk Factors
1.2.2. Comorbidities
1.2.3. Combination of Oncologic Treatments

1.3. Cardiological Assessment before Treatment in Patients without Known Heart Disease

1.3.1. Clinical Assessment
1.3.2. Complementary Tests

1.4. Cardiological Assessment before Treatment in Patients with Known Heart Disease

1.4.1. Clinical Assessment
1.4.2. Complementary Tests

1.5. Monitoring during Treatment of Patients Subjected to Cardiotoxic Treatments

1.5.1. Clinical Assessment
1.5.2. Complementary Tests

Module 2. Arterial Hypertension as a Result of Oncologic Treatments

2.1. Clinical Relevance of Hypertension in Oncology Patients
2.2. Arterial Hypertension Associated with Antiangiogenic Drugs

2.2.1. Incidence
2.2.2. Pathophysiology
2.2.3. Diagnosis

2.3. Other Treatments Associated with the Development of Arterial Hypertension
2.4. Treatment of Arterial Hypertension Related to Oncologic Treatment
2.5. Monitoring Strategy

Module 3. Venous Thromboembolic Disease and Other Vascular Complications in the Oncology Patient

3.1. Venous Thromboembolic Disease in the Oncologic Patient: Clinical Significance

3.1.1. Incidence
3.1.2. Pathophysiology
3.1.3. Risk Factors

3.2. Antineoplastic Treatments Associated with Increased Risk of Thromboembolic Disease

3.2.1. Chemotherapy and Antiangiogenic Drugs
3.2.2. Hormone Therapy

3.3. Prevention of Cancer-Related Venous Thromboembolic Disease

3.3.1. Prevention Strategy in Outpatients with Active Oncology Treatment. Thrombotic Risk Scales
3.3.2. Prevention Strategy in Hospitalized Patients
3.3.3. Periosurgery Prevention Strategy

3.4. Venous Thromboembolic Disease Related to the Use of Central Venous Catheters

3.4.1. Incidence
3.4.2. Clinical Presentation
3.4.3. Diagnostic Methods
3.4.4. Treatment and Monitoring
3.4.5. Prevention

3.5. Forms of Presentation and Diagnosis of Cancer-Associated Thromboembolic Disease

3.5.1. Deep Vein Thrombosis
3.5.2. Pulmonary Embolism

3.6. Treatment of Cancer-Associated Thromboembolic Disease

3.6.1. Initial Treatment
3.6.2. Extended Treatment

3.7. Management of Thromboembolic Disease in Special Situations

3.7.1. Brain Tumors
3.7.2. Obesity
3.7.3. Renal Insufficiency
3.7.4. Thrombopenia

3.8. Primary Prevention of Cardiovascular Disease in Cancer Patients

3.8.1. Incidence and Risk Factors
3.8.2. Implicated Drugs
3.8.3. Clinical Diagnosis and Treatment

3.9. Cerebrovascular Disease

3.9.1. Incidence and Risk Factors
3.9.2. Implicated Treatments
3.9.3. Clinical Diagnosis and Treatment

3.10. Pulmonary Hypertension

3.10.1. Implicated Drugs. Pathophysiology
3.10.2. Clinical Diagnosis
3.10.3. Treatment and Monitoring

Module 4. Complex Clinical Situations in the Context of Cardiotoxicity

4.1. Patient with Complex Cardiovascular Disease Requiring Oncologic Treatment
4.2. Patient with Oncologic Disease Presenting with an Acute Ischemic Event
4.3. Pediatric Patients in Need of Potentially Cardiotoxic Oncology Treatment
4.4. Geriatric Patients in need of Oncologic Treatment
4.5. Oncology Patients Requiring Anticoagulation or Anti-Aggregation
4.6. Oncology Patients who Exhibit Arrhythmias and Require Implantable Devices (Pacemakers, Defibrillators)

A unique, key, and decisive training experience to boost your professional development”